Abstract A series of new aminoguanidine derivatives were synthesized and tested for anti- arrhythmic activity. The compounds selected were investigated on other test models. Finally, compound 13 1-(2, 6-dimethylphenyl)-4, 4-dimethyl-aminoguanidine-hydrochloride (B-GYKI- 38 233) was chosen for detailed study.
